| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.2 | 5e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.23 | 0.0002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |